Nyxoah S.A. (EBR: NYXH)
Belgium
· Delayed Price · Currency is EUR 7.80
-0.04 (-0.51%)
Dec 20, 2024, 9:00 AM CET
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €291.63 million as of December 20, 2024. Its market cap has increased by 136.53% in one year.
Market Cap
291.63M
Enterprise Value
243.99M
Revenue
5.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.80
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 291.63M, a decrease of -30.19%. That is a compound annual growth rate of -8.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 291.63M | 138.75% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | 348.77M | -16.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 36.50B |
| UCB SA | 35.40B |
| Financière de Tubize SA | 6.12B |
| Fagron NV | 1.32B |
| Ion Beam Applications SA | 388.11M |
| Onward Medical N.V. | 218.23M |
| Hyloris Pharmaceuticals SA | 155.12M |
| Sequana Medical NV | 33.95M |